<VariationArchive VariationID="2562345" VariationName="NM_016169.4(SUFU):c.1022del (p.Pro341fs)" VariationType="Deletion" Accession="VCV002562345" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2023-07-08" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2721198" VariationID="2562345">
      <GeneList>
        <Gene Symbol="SUFU" FullName="SUFU negative regulator of hedgehog signaling" GeneID="51684" HGNC_ID="HGNC:16466" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102502819" stop="102633535" display_start="102502819" display_stop="102633535" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="104263718" stop="104393213" display_start="104263718" display_stop="104393213" Strand="+" />
          </Location>
          <OMIM>607035</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_016169.4(SUFU):c.1022del (p.Pro341fs)</Name>
      <CanonicalSPDI>NC_000010.11:102599540:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q24.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102599541" stop="102599541" display_start="102599541" display_stop="102599541" variantLength="1" positionVCF="102599540" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="104359298" stop="104359298" display_start="104359298" display_stop="104359298" variantLength="1" positionVCF="104359297" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>P341fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.104359301del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.104359301del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.102599544del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.102599544del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021338.1" sequenceAccession="NG_021338" sequenceVersion="1" change="g.100583del">
            <Expression>NG_021338.1:g.100583del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178133.2" sequenceAccession="NM_001178133" sequenceVersion="2" change="c.1022del">
            <Expression>NM_001178133.2:c.1022del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171604.1" sequenceAccession="NP_001171604" sequenceVersion="1" change="p.Pro341fs">
            <Expression>NP_001171604.1:p.Pro341fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016169.4" sequenceAccession="NM_016169" sequenceVersion="4" change="c.1022del" MANESelect="true">
            <Expression>NM_016169.4:c.1022del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057253.2" sequenceAccession="NP_057253" sequenceVersion="2" change="p.Pro341fs">
            <Expression>NP_057253.2:p.Pro341fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_521" sequenceAccession="LRG_521">
            <Expression>LRG_521:g.100583del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_521t1" sequenceAccession="LRG_521t1">
            <Expression>LRG_521t1:c.1022del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_521p1" sequenceAccession="LRG_521p1" change="p.Pro341Argfs">
            <Expression>LRG_521p1:p.Pro341Argfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_016169.4(SUFU):c.1022del (p.Pro341fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV003310405" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016169.4(SUFU):c.1022del (p.Pro341fs) AND multiple conditions" Accession="RCV003777135" Version="1">
        <ClassifiedConditionList TraitSetID="23440">
          <ClassifiedCondition DB="MedGen" ID="C0004779">Gorlin syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0025149">Medulloblastoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-07" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-07-08" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22508808</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25403219</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33024317</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="23440" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="381" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Gorlin syndrome</ElementValue>
                <XRef ID="69408002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Basal cell nevus syndrome</ElementValue>
                <XRef ID="UWMG_1854558" DB="CSER _CC_NCGL, University of Washington" />
                <XRef Type="Phenotypic series" ID="PS109400" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7166" />
                <XRef ID="7166" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Nevoid basal cell carcinoma syndrome (NBCCS) is characterized by the development of multiple jaw keratocysts, frequently beginning in the second decade of life, and/or basal cell carcinomas (BCCs) usually from the third decade onward. Approximately 60% of individuals have a recognizable appearance with macrocephaly, frontal bossing, coarse facial features, and facial milia. Most individuals have skeletal anomalies (e.g., bifid ribs, wedge-shaped vertebrae). Ectopic calcification, particularly in the falx, is present in more than 90% of affected individuals by age 20 years. Cardiac and ovarian fibromas occur in approximately 2% and 20% of individuals respectively. Approximately 5% of all children with NBCCS develop medulloblastoma (primitive neuroectodermal tumor), generally the desmoplastic subtype. The risk of developing medulloblastoma is substantially higher in individuals with an SUFU pathogenic variant (33%) than in those with a PTCH1 pathogenic variant (&lt;2%). Peak incidence is at age one to two years. Life expectancy in NBCCS is not significantly different from average.</Attribute>
                <XRef ID="NBK1151" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301330</ID>
                <ID Source="BookShelf">NBK1151</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21304560</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="377" DB="Orphanet" />
              <XRef ID="C0004779" DB="MedGen" />
              <XRef ID="MONDO:0007187" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS109400" DB="OMIM" />
            </Trait>
            <Trait ID="2738" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Medulloblastoma</ElementValue>
                <XRef ID="Medulloblastoma/4552" DB="Genetic Alliance" />
                <XRef ID="HP:0002885" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0007959" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Medulloblastoma, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MEDULLOBLASTOMA PREDISPOSITION SYNDROME</ElementValue>
                <XRef Type="MIM" ID="155255" DB="OMIM" />
                <XRef Type="Allelic variant" ID="612250.0002" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDB</ElementValue>
                <XRef Type="MIM" ID="155255" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7005" />
                <XRef ID="7005" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Central Nervous System Cancers, 2023</CitationText>
              </Citation>
              <XRef ID="616" DB="Orphanet" />
              <XRef ID="C0025149" DB="MedGen" />
              <XRef ID="D008527" DB="MeSH" />
              <XRef ID="MONDO:0007959" DB="MONDO" />
              <XRef Type="MIM" ID="155255" DB="OMIM" />
              <XRef Type="primary" ID="HP:0002885" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8539137" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="15008361|MedGen:C0004779;C0025149" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004584345" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22508808</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25403219</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33024317</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro341Argfs*20) in the SUFU gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SUFU are known to be pathogenic (PMID: 22508808, 25403219, 33024317). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SUFU-related conditions. ClinVar contains an entry for this variant (Variation ID: 2562345). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SUFU" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.104359298del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0004779" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0025149" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7422367" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2023-07-08">
        <ClinVarSubmissionID localKey="a8891606|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004001038" DateUpdated="2024-05-01" DateCreated="2023-07-08" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1022delC pathogenic mutation, located in coding exon 8 of the SUFU gene, results from a deletion of one nucleotide at nucleotide position 1022, causing a translational frameshift with a predicted alternate stop codon (p.P341Rfs*20). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SUFU" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016169.3:c.1022delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough061523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7422367" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8539137" TraitType="Disease" MappingType="XRef" MappingValue="C0025149" MappingRef="MedGen">
        <MedGen CUI="C0025149" Name="Medulloblastoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8539137" TraitType="Disease" MappingType="XRef" MappingValue="C0004779" MappingRef="MedGen">
        <MedGen CUI="C0004779" Name="Gorlin syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

